[HTML][HTML] Immune activation, inflammation, and non-AIDS co-morbidities in HIV-infected patients under long-term ART
Despite effective antiretroviral therapy (ART), people living with HIV (PLWH) still present
persistent chronic immune activation and inflammation. This condition is the result of several …
persistent chronic immune activation and inflammation. This condition is the result of several …
[HTML][HTML] Humoral and cellular response following vaccination with the BNT162b2 mRNA COVID-19 vaccine in patients affected by primary immunodeficiencies
…, C Pighi, N Cotugno, C Medri, E Morrocchi… - Frontiers in …, 2021 - frontiersin.org
Mass SARS-Cov-2 vaccination campaign represents the only strategy to defeat the global
pandemic we are facing. Immunocompromised patients represent a vulnerable population at …
pandemic we are facing. Immunocompromised patients represent a vulnerable population at …
[PDF][PDF] Virological and immunological features of SARS-CoV-2-infected children who develop neutralizing antibodies
As the global COVID-19 pandemic progresses, it is paramount to gain knowledge on
adaptive immunity to SARS-CoV-2 in children to define immune correlates of protection upon …
adaptive immunity to SARS-CoV-2 in children to define immune correlates of protection upon …
Modeling human immune responses to vaccination in vitro
The human immune system is a complex network of coordinated components that are crucial
for health and disease. Animal models, commonly used to study immunomodulatory agents…
for health and disease. Animal models, commonly used to study immunomodulatory agents…
[HTML][HTML] Evaluation of safety and immunogenicity of BNT162B2 mRNA COVID-19 vaccine in IBD pediatric population with distinct immune suppressive regimens
…, V Santilli, GA Rotulo, C Pighi, C Medri, E Morrocchi… - Vaccines, 2022 - mdpi.com
Patients affected by Inflammatory Bowel Disease (IBD) present higher risk for infection and
suboptimal response upon vaccination. The immunogenicity of SARS-CoV2 vaccination is …
suboptimal response upon vaccination. The immunogenicity of SARS-CoV2 vaccination is …
Virological and immunological features of SARS‐COV‐2 infected children with distinct symptomatology
…, R Cutrera, A Villani, E Morrocchi… - Pediatric Allergy and …, 2021 - Wiley Online Library
Background Although SARS‐CoV‐2 immunizations have started in most countries, children
are not currently included in the vaccination programs; thus, it remains crucial to define their …
are not currently included in the vaccination programs; thus, it remains crucial to define their …
[HTML][HTML] Similarities and differences between myocarditis following COVID-19 mRNA vaccine and multiple inflammatory syndrome with cardiac involvement in children
…, C Rossetti, EC Manno, C Pighi, E Morrocchi… - Clinical …, 2023 - Elsevier
Despite the multiple benefits of vaccination, cardiac adverse Events Following COVID-19
Immunization (c-AEFI) have been reported. These events as well as the severe cardiac …
Immunization (c-AEFI) have been reported. These events as well as the severe cardiac …
N‐glycan engineering of a plant‐produced anti‐CD20‐hIL‐2 immunocytokine significantly enhances its effector functions
…, F Novelli, C Lonoce, E Morrocchi… - Biotechnology and …, 2018 - Wiley Online Library
Anti‐CD20 recombinant antibodies are among the most promising therapeutics for the
treatment of B‐cell malignancies such as non‐Hodgkin lymphomas. We recently demonstrated …
treatment of B‐cell malignancies such as non‐Hodgkin lymphomas. We recently demonstrated …
[HTML][HTML] How CD4+ T Cells Transcriptional Profile Is Affected by Culture Conditions: Towards the Design of Optimal In Vitro HIV Reactivation Assays
GR Pascucci, E Morrocchi, C Pighi, A Rotili, A Neri… - Biomedicines, 2023 - mdpi.com
Most of the current assays directed at the investigation of HIV reactivation are based on cultures
of infected cells such as Peripheral Blood Mononuclear Cells (PBMCs) or isolated CD4 …
of infected cells such as Peripheral Blood Mononuclear Cells (PBMCs) or isolated CD4 …
BNT162B2 mRNA COVID-19 vaccine in heart and lung transplanted young adults: is an alternative SARS-CoV-2 immune response surveillance needed?
N Cotugno, C Pighi, E Morrocchi, A Ruggiero… - …, 2022 - journals.lww.com
In the present study, we report the safety profile and the immunogenicity of the BNT162B2
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)(Pfizer-Biontech) in a cohort …
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)(Pfizer-Biontech) in a cohort …